Kuehn Law Encourages CHRD, AVRO, KAMN, and CTLT Investors to Contact Law Firm
Kuehn Law Encourages CHRD, AVRO, KAMN, and CTLT Investors to Contact Law Firm
PR Newswire
NEW YORK, Feb. 27, 2024
NEW YORK, Feb. 27, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies.
Kuehn Law is investigating whether the Boards of the below companies 1) acted to maximize shareholder value, 2) failed to disclose material information, and 3) conducted a fair process:
- Chord Energy Corporation (Nasdaq: CHRD) click to participate
Chord Energy has agreed to merge with Enerplus Corporation. Under the agreement, shareholders of Enerplus will receive 0.10125 shares of Chord common stock and $1.84 per share in cash. - AVROBIO, Inc. (Nasdaq: AVRO) click to participate
AVROBIO has agreed to merge with Tectonic Therapeutic. Under the agreement, current shareholders of AVROBIO are anticipated to hold about 22.3% of the merged entity. - Kaman Corp. (NYSE: KAMN) click to participate
Kaman has reached a deal to be quired by Arcline Investment Management, L.P. In this deal, each Kaman shareholder will be paid $46.00 per share in a cash transaction. - Catalent, Inc. (NYSE: CTLT) click to participate
Novo Holdings has agreed to purchase Catalent. In accordance with the merger agreement, Catalent shareholders will receive $63.50 per share in cash.
Why Your Participation Matters:
As a shareholder your voice matters, and by getting involved, you contribute to the integrity and fairness of the financial markets. Your investment. Your voice. Your future.™
How to Get Involved:
Kuehn Law is dedicated to safeguarding shareholder interests. Concerned shareholders are encouraged to contact Justin Kuehn, Esq., at justin@kuehn.law or call (833) 672-0814. Kuehn Law covers all case costs and does not charge its investor clients. Shareholders are advised to act promptly, as legal rights may be time-sensitive. For additional information, please visit Merger Litigation - Kuehn Law.
Attorney advertising. Prior results do not guarantee similar outcomes.
Contacts:
Kuehn Law, PLLC
Justin Kuehn, Esq.
53 Hill Street, Suite 605
Southampton, NY 11968
justin@kuehn.law
(833) 672-0814
SOURCE Kuehn Law, PLLC
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth